Researchers from Hospital Israelita Albert Einstein in Brazil were the week of March 10-16 at Hadassah, learning from Prof. Michal Lotem in order to bring advanced cell therapy to their country.

They explained that only basic immunotherapy is available in Brazil and those with financial means travel to other countries for advanced treatment. Dr. Gustavo Shvartsman who led the Brazilian delegation shared his desire to bring advanced immunotherapy treatment to all Brazilians through this learning partnership with Hadassah. Said Dr. Shvartsman, “At Hadassah we learned how to position this new project for the future of immunotherapies.” Said Prof. Lotem, “I always question what our responsibility is as doctors to society. I was saddened to learn about the disparities in cancer treatment in Brazil. But I am encouraged by your presence here at Hadassah to learn and bring cutting edge immunotherapy to Brazil.”

The training happened at “The Dayan Family (Brazil) Immunotherapy Cancer Laboratory” under the auspices of Roberto Bielawski from Brazil.

We will return with a more detailed material on this subject.